SSGJ707
Phase 2- Indications
- Non-small cell lung cancer, Metastatic colorectal cancer
Company intelligence / Profile preview
Sansheng Pharmaceutical
Xinxiang, Henan, China
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Sansheng Pharmaceutical operates as a diversified pharmaceutical group with a strong focus on R&D, manufacturing, and marketing of both small molecule drugs and biologics. Its portfolio includes commercialized products such as etanercept biosimilars for autoimmune diseases and HER2-targeted therapies for breast cancer. The company has an extensive pipeline of over two dozen programs spanning oncology, autoimmune disorders, nephrology, dermatology, hematology/oncology—with several at late-stage clinical development or NDA/BLA filing stage. Recent high-profile deals include outlicensing a PD‑1/VEGF bispecific antibody to Pfizer with record upfront payments.
- Therapeutic areas
- OncologyCardiovascularImmunologyHematology
- Modalities
- Small moleculesMonoclonal antibodies/biologics
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Pfizer (global license for SSGJ–707 PD–1/VEGF bispecific)Cornerstone Pharmaceuticals (license agreement for anti-PD–1 monoclonal antibody Nofazinlimab)
Beyond the preview
Go deeper on Sansheng Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sansheng Pharmaceutical.